The scientist’s investigation covers issues in Virology, Virus, Ebola virus, Vaccination and Marburgvirus. His study in Virology is interdisciplinary in nature, drawing from both Vaccinia, Orthopoxvirus and Antibody, Immunology. The Viral hemorrhagic fever research Alan L. Schmaljohn does as part of his general Immunology study is frequently linked to other disciplines of science, such as Epidemiology, therefore creating a link between diverse domains of science.
His Virus research integrates issues from Recombinant virus and Monoclonal antibody. His work on Ebolavirus as part of general Ebola virus research is frequently linked to Filoviridae and Mononegavirales, bridging the gap between disciplines. His Marburgvirus study combines topics in areas such as Jurkat cells, Viral entry, Syncytium and Transfection.
Alan L. Schmaljohn mainly focuses on Virology, Virus, Antibody, Ebola virus and Monoclonal antibody. His Virology study focuses on Marburg virus in particular. His Marburg virus research focuses on Microbiology and how it relates to Virus-like particle, VP40 and Viral Vaccine.
His work on Hantavirus, Hantaan virus, Alphavirus and Viral envelope as part of general Virus research is frequently linked to Mononegavirales, thereby connecting diverse disciplines of science. His Antibody study incorporates themes from Sindbis virus, In vivo and Glycoprotein. He is studying Ebolavirus, which is a component of Ebola virus.
Alan L. Schmaljohn mainly investigates Virology, Virus, Ebola virus, Marburg virus and Filoviridae. Vaccination is the focus of his Virology research. Alan L. Schmaljohn interconnects Smallpox vaccine, Orthopoxvirus, Vaccinia, Dryvax and Monkeypox virus in the investigation of issues within Vaccination.
His Virus research incorporates elements of Receptor, Computational biology and In vivo. His Ebola virus study integrates concerns from other disciplines, such as Infectious disease, Intensive care medicine, Variola virus and Smallpox. His Marburg virus study combines topics in areas such as Mutation, Gene mutation and RNA.
Virology, Ebola virus, Filoviridae, Microbiology and Marburg virus are his primary areas of study. He studies Vaccination which is a part of Virology. His research integrates issues of Vaccinia, ACAM2000, Orthopoxvirus and Dryvax in his study of Vaccination.
His Ebola virus research includes themes of Immune system and Innate immunology. His Filoviridae research includes elements of Virus-like particle, Mononegavirales, VP40, Virus and Viral matrix protein. His study in Microbiology is interdisciplinary in nature, drawing from both Marburgvirus and Ebola Hemorrhagic Fever.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Hemorrhagic Fever Viruses as Biological Weapons: Medical and Public Health Management
Luciana Borio;Thomas Inglesby;C. J. Peters;Alan L. Schmaljohn.
Epitopes involved in antibody-mediated protection from Ebola virus.
Julie A. Wilson;Michael Hevey;Russell Bakken;Shawn Guest.
Lipid Raft Microdomains A Gateway for Compartmentalized Trafficking of Ebola and Marburg Viruses
Sina Bavari;Catharine M. Bosio;Elizabeth Wiegand;Gordon Ruthel.
Journal of Experimental Medicine (2002)
Marburg Virus Vaccines Based upon Alphavirus Replicons Protect Guinea Pigs and Nonhuman Primates
Michael Hevey;Diane Negley;Peter Pushko;Jonathan Smith.
Ebola and Marburg Viruses Replicate in Monocyte-Derived Dendritic Cells without Inducing the Production of Cytokines and Full Maturation
Catharine M. Bosio;M. Javad Aman;Case Grogan;Robert Hogan.
The Journal of Infectious Diseases (2003)
Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis
A. L. Schmaljohn;E. D. Johnson;J. M. Dalrymple;G. A. Cole.
Hantaan virus M RNA: coding strategy, nucleotide sequence, and gene order
Connie S Schmaljohn;Alan L Schmaljohn;Joel M Dalrymple.
Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants.
Connie S. Schmaljohn;Yong-Kyu Chu;Alan L. Schmaljohn;Joel M. Dalrymple.
Journal of Virology (1990)
Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.
Peter Pushko;Mike Bray;George V Ludwig;Michael Parker.
Ebola virus-like particles protect from lethal Ebola virus infection
Kelly L. Warfield;Catharine M. Bosio;Brent C. Welcher;Emily M. Deal.
Proceedings of the National Academy of Sciences of the United States of America (2003)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: